• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Human papillomavirus (HPV) detection using in situ hybridization in histologic samples: correlations with cytologic changes and polymerase chain reaction HPV detection.原位杂交法检测组织学样本中的人乳头瘤病毒(HPV):与细胞学改变及聚合酶链反应 HPV 检测的相关性。
Am J Clin Pathol. 2011 Jul;136(1):119-27. doi: 10.1309/AJCP03HUQYZMWATP.
2
Genital human papillomavirus testing by in situ hybridization in liquid atypical cytologic materials and follow-up biopsies.通过原位杂交技术对液体非典型细胞学材料及后续活检组织进行生殖道人乳头瘤病毒检测。
Acta Cytol. 2005 Mar-Apr;49(2):127-31. doi: 10.1159/000326119.
3
Comparison of hybrid capture 2 with in situ hybridization for the detection of high-risk human papillomavirus in liquid-based cervical samples.杂交捕获2法与原位杂交法在液基宫颈样本中检测高危型人乳头瘤病毒的比较
Cancer. 2004 Feb 25;102(1):11-8. doi: 10.1002/cncr.11904.
4
Role of HPV DNA testing in predicting cervical intraepithelial lesions: comparison of HC HPV and ISH HPV.人乳头瘤病毒(HPV)DNA检测在预测宫颈上皮内病变中的作用:杂交捕获法HPV与原位杂交法HPV的比较
Diagn Cytopathol. 2003 Sep;29(3):149-55. doi: 10.1002/dc.10356.
5
Signal-amplified colorimetric in situ hybridization for assessment of human papillomavirus infection in cervical lesions.用于评估宫颈病变中人乳头瘤病毒感染的信号放大比色原位杂交技术
Mod Pathol. 2001 Jul;14(7):702-9. doi: 10.1038/modpathol.3880375.
6
Comparison of light microscopy, in situ hybridization and polymerase chain reaction for detection of human papillomavirus in histological tissue of cervical intraepithelial neoplasia.光镜检查、原位杂交和聚合酶链反应检测宫颈上皮内瘤变组织学组织中人乳头瘤病毒的比较
APMIS. 1997 Feb;105(2):115-20. doi: 10.1111/j.1699-0463.1997.tb00549.x.
7
Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.人乳头瘤病毒检测用于子宫颈异常初步筛查的评估:敏感性、特异性及转诊频率的比较
JAMA. 2002 Oct 9;288(14):1749-57. doi: 10.1001/jama.288.14.1749.
8
Evaluation of a commercialized in situ hybridization assay for detecting human papillomavirus DNA in tissue specimens from patients with cervical intraepithelial neoplasia and cervical carcinoma.评估一种商业化的原位杂交检测方法,用于检测宫颈上皮内瘤变和宫颈癌患者组织标本中的人乳头瘤病毒DNA。
J Clin Microbiol. 2008 Jan;46(1):274-80. doi: 10.1128/JCM.01299-07. Epub 2007 Oct 31.
9
Comparison between the Hybrid Capture II test and a PCR-based human papillomavirus detection method for diagnosis and posttreatment follow-up of cervical intraepithelial neoplasia.杂交捕获II检测法与基于聚合酶链反应的人乳头瘤病毒检测方法在宫颈上皮内瘤变诊断及治疗后随访中的比较
J Clin Microbiol. 2005 Jul;43(7):3260-6. doi: 10.1128/JCM.43.7.3260-3266.2005.
10
Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions.自我采集的阴道、外阴和尿液样本与医生采集的宫颈样本用于人乳头瘤病毒检测以发现高级别鳞状上皮内病变的比较。
CMAJ. 2000 Sep 5;163(5):513-8.

引用本文的文献

1
High-Risk HPV CISH Detection in Cervical Biopsies with Weak and/or Focal p16 Immunohistochemical Positivity.高危型 HPV 原位杂交检测在宫颈活检中弱表达和/或局灶性 p16 免疫组化阳性的应用。
Int J Mol Sci. 2024 May 14;25(10):5354. doi: 10.3390/ijms25105354.
2
Human papillomavirus genotype distribution patterns in Zimbabwe; is the bivalent vaccine sufficient?津巴布韦人乳头瘤病毒基因型分布模式;二价疫苗是否足够?
Intervirology. 2024 Apr 4;67(1):55-63. doi: 10.1159/000531347.
3
Novel computational and drug design strategies for inhibition of human papillomavirus-associated cervical cancer and DNA polymerase theta receptor by Apigenin derivatives.新型计算和药物设计策略,通过芹菜素衍生物抑制人乳头瘤病毒相关宫颈癌和 DNA 聚合酶 θ 受体。
Sci Rep. 2023 Oct 2;13(1):16565. doi: 10.1038/s41598-023-43175-x.
4
Detection of Human Papillomavirus in Squamous Lesions of the Conjunctiva Using RNA and DNA In-Situ Hybridization.应用 RNA 和 DNA 原位杂交技术检测结膜鳞状病变中人乳头瘤病毒。
Int J Mol Sci. 2022 Jun 29;23(13):7249. doi: 10.3390/ijms23137249.
5
Cytology versus HPV testing for cervical cancer screening in the general population.普通人群宫颈癌筛查中细胞学检查与HPV检测的比较
Cochrane Database Syst Rev. 2017 Aug 10;8(8):CD008587. doi: 10.1002/14651858.CD008587.pub2.
6
Current and Emerging Molecular Tests for Human Papillomavirus-Related Neoplasia in the Genomic Era.基因组时代人乳头瘤病毒相关肿瘤的现有及新兴分子检测方法
J Mol Diagn. 2017 May;19(3):366-377. doi: 10.1016/j.jmoldx.2017.01.006. Epub 2017 Mar 18.
7
Human Papillomavirus Laboratory Testing: the Changing Paradigm.人乳头瘤病毒实验室检测:不断变化的模式
Clin Microbiol Rev. 2016 Apr;29(2):291-319. doi: 10.1128/CMR.00013-15.
8
Recent Progress in Therapeutic Treatments and Screening Strategies for the Prevention and Treatment of HPV-Associated Head and Neck Cancer.人乳头瘤病毒相关头颈癌预防与治疗的治疗方法及筛查策略的最新进展
Viruses. 2015 Sep 17;7(9):5040-65. doi: 10.3390/v7092860.
9
An intelligent clinical decision support system for patient-specific predictions to improve cervical intraepithelial neoplasia detection.一种用于患者特异性预测以改善宫颈上皮内瘤变检测的智能临床决策支持系统。
Biomed Res Int. 2014;2014:341483. doi: 10.1155/2014/341483. Epub 2014 Apr 9.
10
Is real-time PCR the correct method to evaluate the incidence of human papillomavirus in prepuces of asymptomatic boys and men?实时荧光定量PCR是评估无症状男孩和男性包皮中人乳头瘤病毒感染率的正确方法吗?
World J Urol. 2014 Oct;32(5):1199-204. doi: 10.1007/s00345-013-1190-4. Epub 2013 Oct 22.

本文引用的文献

1
Using biomarkers as objective standards in the diagnosis of cervical biopsies.在宫颈活检诊断中使用生物标志物作为客观标准。
Am J Surg Pathol. 2010 Aug;34(8):1077-87. doi: 10.1097/PAS.0b013e3181e8b2c4.
2
Hybrid capture vs. PCR screening of cervical human papilloma virus infections. Cytological and histological associations in 1270 women.杂交捕获法与聚合酶链反应检测宫颈人乳头瘤病毒感染。1270 例女性的细胞学和组织学相关性研究。
BMC Cancer. 2010 Feb 22;10:53. doi: 10.1186/1471-2407-10-53.
3
Molecular detection methods of human papillomavirus (HPV).人乳头瘤病毒(HPV)的分子检测方法。
Int J Biol Markers. 2009 Oct-Dec;24(4):215-22. doi: 10.1177/172460080902400401.
4
Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial.人乳头瘤病毒检测在宫颈癌及宫颈上皮内瘤变筛查中的作用:一项随机对照试验。
Lancet Oncol. 2010 Mar;11(3):249-57. doi: 10.1016/S1470-2045(09)70360-2. Epub 2010 Jan 18.
5
An analysis on the combination expression of HPV L1 capsid protein and p16INK4a in cervical lesions.宫颈病变中HPV L1衣壳蛋白与p16INK4a联合表达的分析
Diagn Cytopathol. 2010 Aug;38(8):573-8. doi: 10.1002/dc.21258.
6
HPV vaccine protein L1 predicts disease outcome of high-risk HPV+ early squamous dysplastic lesions.人乳头瘤病毒疫苗蛋白L1可预测高危人乳头瘤病毒阳性早期鳞状发育异常病变的疾病转归。
Am J Clin Pathol. 2009 Dec;132(6):840-5. doi: 10.1309/AJCPCU0HBFFFGDTV.
7
Effect of human papillomavirus on cell cycle-related proteins p16, Ki-67, Cyclin D1, p53, and ProEx C in precursor lesions of cervical carcinoma: a tissue microarray study.人乳头瘤病毒对宫颈癌前病变中细胞周期相关蛋白p16、Ki-67、细胞周期蛋白D1、p53和ProEx C的影响:一项组织芯片研究
Am J Clin Pathol. 2009 Sep;132(3):378-90. doi: 10.1309/AJCPO0WY1VIFCYDC.
8
Predictors of human papillomavirus persistence among women with equivocal or mildly abnormal cytology.HPV 持续感染的预测因素:细胞学检查结果为不明确意义的非典型鳞状细胞或轻度异常的女性。
Int J Cancer. 2010 Feb 1;126(3):684-91. doi: 10.1002/ijc.24752.
9
HPV screening for cervical cancer in rural India.印度农村地区宫颈癌的人乳头瘤病毒筛查
N Engl J Med. 2009 Apr 2;360(14):1385-94. doi: 10.1056/NEJMoa0808516.
10
HPV in situ hybridization signal patterns as a marker for cervical intraepithelial neoplasia progression.人乳头瘤病毒原位杂交信号模式作为宫颈上皮内瘤变进展的标志物
Gynecol Oncol. 2009 Jan;112(1):114-8. doi: 10.1016/j.ygyno.2008.09.047. Epub 2008 Nov 12.

原位杂交法检测组织学样本中的人乳头瘤病毒(HPV):与细胞学改变及聚合酶链反应 HPV 检测的相关性。

Human papillomavirus (HPV) detection using in situ hybridization in histologic samples: correlations with cytologic changes and polymerase chain reaction HPV detection.

机构信息

Department of Medicine, Division of Infectious Diseases, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.

出版信息

Am J Clin Pathol. 2011 Jul;136(1):119-27. doi: 10.1309/AJCP03HUQYZMWATP.

DOI:10.1309/AJCP03HUQYZMWATP
PMID:21685039
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8053314/
Abstract

Although in situ hybridization (ISH) and polymerase chain reaction (PCR) have extensively been used on cytology specimens, there have been limited reports of the usefulness of these techniques in relation to confirmed histologic findings. In this study, we used PCR and ISH to detect human papillomavirus (HPV) in cytologic and histologic specimens, respectively. By using positive and negative likelihood ratios, we attempted to identify any predictive role of ISH testing alone or in combination with PCR for the development of high-grade histologic lesions (cervical intraepithelial neoplasia [CIN] 2+). In our study, ISH was a useful method for detection of HPV, even in a large fraction of samples with normal cytologic or biopsy findings. We suggest that when used together and evaluated in conjunction with histologic sections, ISH is a useful tool for ancillary molecular testing of HPV infection in cervical lesions, especially in CIN 2+ histological lesions where its analytic sensitivities and specificities were as good as those of PCR testing.

摘要

虽然原位杂交(ISH)和聚合酶链反应(PCR)已广泛应用于细胞学标本,但关于这些技术与明确的组织学发现的相关性的有用性的报道有限。在这项研究中,我们分别使用 PCR 和 ISH 检测细胞学和组织学标本中的人乳头瘤病毒(HPV)。通过使用阳性和阴性似然比,我们试图确定 ISH 检测单独或与 PCR 联合检测对高级别组织学病变(宫颈上皮内瘤变[CIN]2+)发展的任何预测作用。在我们的研究中,ISH 是一种检测 HPV 的有用方法,即使在细胞学或活检结果正常的大量样本中也是如此。我们建议,当与组织学切片一起使用并进行评估时,ISH 是一种有用的工具,可用于辅助检测宫颈病变中的 HPV 感染,尤其是在 CIN 2+组织学病变中,其分析灵敏度和特异性与 PCR 检测相当。